Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

Partnership based on a highly protective vaccine candidate identified by Evaxion’s EDEN™ platformThe collaboration will access mRNA technology from the WHO and Medicines Patent Pool’s mRNA...

Related Keywords

Ukraine ,Copenhagen ,Køavn ,Denmark ,Russia ,South Africa ,Petro Terblanche ,Afrigen Biologics ,Christian Kanstrup ,Avacare Healthcare Group ,Rna Technology Transfer Programme ,World Health Organization ,Mrna Vaccine Technology Transfer Hub ,Securities Exchange ,Industrial Development Corporation ,Rna Programme ,Exchange Commission ,Medicines Patent Pool ,Chief Scientific Officer ,Managing Director Professor Petro Terblanche ,Cape Town Based ,Transfer Programme ,Securities Act ,Securities Exchange Act ,Annual Report ,Markets ,